We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $2.05B
1-Year Est. Return 43.16%
This Fund
S&P 500
This Quarter Est. Return
+11.17%
1 Year Est. Return
+43.16%
3 Year Est. Return
+139.79%
5 Year Est. Return
+169.96%
10 Year Est. Return
+906.29%
AUM
$1.75B
AUM Growth
+$24.7M
Cap. Flow
-$74.5M
Cap. Flow %
-4.25%
Top 10 Hldgs %
27.66%
Holding
275
New
15
Increased
70
Reduced
162
Closed
18

Top Buys

Rank Stock Value
1
ALKS icon
Alkermes
ALKS
+$10.8M
2
WNS
WNS Holdings
WNS
+$9.49M
3
FN icon
Fabrinet
FN
+$8.56M
4
ADMA icon
ADMA Biologics
ADMA
+$6.59M
5
YOU icon
Clear Secure
YOU
+$5.91M

Top Sells

Rank Stock Value
1
PGTI
PGT, Inc.
PGTI
+$25.4M
2
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$15.9M
3
DOOR
MASONITE INTERNATIONAL CORP
DOOR
+$10.2M
4
CHUY
Chuy's Holdings, Inc. Common Stock
CHUY
+$6.67M
5
BBBY
Bed Bath & Beyond
BBBY
+$5.67M

Sector Composition

Rank Sector Weight
1 Healthcare 31.67%
2 Technology 23.6%
3 Industrials 20.27%
4 Communication Services 5.79%
5 Consumer Staples 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IWO icon
201
iShares Russell 2000 Growth ETF
IWO
$14.9B
$1.32M 0.08%
4,891
-8,923
-65% -$2.28M
BWXT icon
202
BWX Technologies
BWXT
$15.5B
$1.28M 0.07%
12,429
-7,743
-38% -$693K
VMC icon
203
Vulcan Materials
VMC
$37B
$1.27M 0.07%
4,648
-3,425
-42% -$844K
AXGN icon
204
Axogen
AXGN
$2.59B
$1.24M 0.07%
+153,174
New +$1.37M
BRK.B icon
205
Berkshire Hathaway Class B
BRK.B
$1.14T
$1.18M 0.07%
2,800
– –
CW icon
206
Curtiss-Wright
CW
$25.6B
$1.11M 0.06%
4,354
-2,887
-40% -$671K
DOV icon
207
Dover
DOV
$28.3B
$1.08M 0.06%
6,082
-128
-2% -$20.6K
URGN icon
208
UroGen Pharma
URGN
$2.26B
$1.06M 0.06%
70,406
+514
+0.7% +$8.4K
BRKR icon
209
Bruker
BRKR
$8.58B
$992K 0.06%
10,565
-6,959
-40% -$560K
AEHR icon
210
Aehr Test Systems
AEHR
$3.46B
$958K 0.05%
+77,287
New +$1.29M
ABBV icon
211
AbbVie
ABBV
$438B
$861K 0.05%
4,727
-109
-2% -$18.8K
IEX icon
212
IDEX
IEX
$17.2B
$847K 0.05%
3,469
-77
-2% -$17.4K
UPLD icon
213
Upland Software
UPLD
$14.5M
$815K 0.05%
26,382
-12,111
-31% -$439K
SRRK icon
214
Scholar Rock
SRRK
$6.32B
$789K 0.05%
44,406
+326
+0.7% +$5.13K
CDW icon
215
CDW
CDW
$17.1B
$782K 0.04%
3,057
-101
-3% -$24K
PBYI icon
216
Puma Biotechnology
PBYI
$442M
$743K 0.04%
140,106
-189,764
-58% -$1.02M
TBRG
217
DELISTED
TruBridge
TBRG
$741K 0.04%
80,336
+4,507
+6% +$43.6K
TECH icon
218
Bio-Techne
TECH
$11.2B
$725K 0.04%
10,299
-4,133
-29% -$296K
TDY icon
219
Teledyne Technologies
TDY
$32B
$711K 0.04%
1,657
+207
+14% +$88.8K
CR icon
220
Crane Co
CR
$12.7B
$675K 0.04%
4,992
-4,721
-49% -$581K
ZBH icon
221
Zimmer Biomet
ZBH
$18.7B
$658K 0.04%
4,987
-4,172
-46% -$521K
DENN
222
DELISTED
Denny's
DENN
$656K 0.04%
73,235
+98
+0.1% +$962
EW icon
223
Edwards Lifesciences
EW
$53B
$652K 0.04%
6,818
-4,831
-41% -$406K
BRK.A icon
224
Berkshire Hathaway Class A
BRK.A
$1.14T
$634K 0.04%
1
– –
CVX icon
225
Chevron
CVX
$382B
$589K 0.03%
3,737
– –
7 8
9
10 11

Similar funds

RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
IL
Investure LLC Charlottesville, Virginia $2.04B AUM 15.91% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM

Rice Hall James & Associates's Q1 2024 Portfolio in Review

As of Q1 2024, Rice Hall James & Associates held 275 positions worth $1.75B, up 1.4% from $1.73B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rice Hall James & Associates withdrew a net $74.5M in Q1 2024, closing 18 positions and reducing 162 holdings. Its most notable exit was PGT, Inc., an estimated $25.4M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 30% a quarter earlier, followed by Technology and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in ADMA Biologics worth $7.96M.

  • Rice Hall James & Associates's largest Q1 2024 buy was ADMA Biologics: 1,206,499 shares worth $7.96M.
  • Rice Hall James & Associates added most to Alkermes in Q1 2024, an estimated $10.8M increase.
  • Rice Hall James & Associates's biggest Q1 2024 reduction was MASONITE INTERNATIONAL CORP, cutting an estimated $10.2M.
  • Rice Hall James & Associates fully exited PGT, Inc. in Q1 2024, selling an estimated $25.4M.
  • Rice Hall James & Associates's ten largest holdings make up 28% of its $1.75B portfolio in Q1 2024.
  • Rice Hall James & Associates opened 15 new positions and closed 18 in Q1 2024.
  • Rice Hall James & Associates's portfolio value rose 1.4% quarter-over-quarter to $1.75B.

Based on Rice Hall James & Associates's 13F filing for Q1 2024, filed 23 Apr 2024.